The trial is utilizing the Montreal Cognitive Assessment
(MoCA) Scale to screen for cognition based on a sub study
comparison of theMoCA and theMMSE conducted in parallel
to the study reported here. The MoCa has demonstrated
higher sensitivity in detecting mild cognitive impairment
(90%) when compared to the MMSE (90%) in other older
client populations (Nasreddine et al., 2005).